203 related articles for article (PubMed ID: 34389926)
1. Myosteatosis at diagnosis is adversely associated with 2-year survival in women with estrogen receptor-negative metastatic breast cancer.
Sheean P; Gomez-Perez S; Joyce C; O'Connor P; Bojko M; Smith A; Vasilopoulos V; Rao R; Sclamberg J; Robinson P
Breast Cancer Res Treat; 2021 Nov; 190(1):121-132. PubMed ID: 34389926
[TBL] [Abstract][Full Text] [Related]
2. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
[TBL] [Abstract][Full Text] [Related]
3. The association of body composition parameters and adverse events in women receiving chemotherapy for early breast cancer.
Aleixo GFP; Shachar SS; Deal AM; Nyrop KA; Muss HB; Chen YT; Yu H; Williams GR
Breast Cancer Res Treat; 2020 Aug; 182(3):631-642. PubMed ID: 32519169
[TBL] [Abstract][Full Text] [Related]
4. Body Composition, Serum Biomarkers of Inflammation and Quality of Life in Clinically Stable Women with Estrogen Receptor Positive Metastatic Breast Cancer.
Sheean P; Gomez-Perez S; Joyce C; Vasilopoulos V; Bartolotta MB; Robinson P; Lo S; Lomasney L
Nutr Cancer; 2019; 71(6):981-991. PubMed ID: 31037968
[TBL] [Abstract][Full Text] [Related]
5. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
Findlay M; White K; Brown C; Bauer JD
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
[TBL] [Abstract][Full Text] [Related]
6. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
7. The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - A retrospective register study.
Aro R; Mäkäräinen-Uhlbäck E; Ämmälä N; Rautio T; Ohtonen P; Saarnio J; Meriläinen S
Eur J Surg Oncol; 2020 Sep; 46(9):1656-1662. PubMed ID: 32224072
[TBL] [Abstract][Full Text] [Related]
8. Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer.
Caan BJ; Cespedes Feliciano EM; Prado CM; Alexeeff S; Kroenke CH; Bradshaw P; Quesenberry CP; Weltzien EK; Castillo AL; Olobatuyi TA; Chen WY
JAMA Oncol; 2018 Jun; 4(6):798-804. PubMed ID: 29621380
[TBL] [Abstract][Full Text] [Related]
9. Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.
Shachar SS; Deal AM; Weinberg M; Nyrop KA; Williams GR; Nishijima TF; Benbow JM; Muss HB
Clin Cancer Res; 2017 Feb; 23(3):658-665. PubMed ID: 27489287
[TBL] [Abstract][Full Text] [Related]
10. Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review.
Aleixo GFP; Williams GR; Nyrop KA; Muss HB; Shachar SS
Breast Cancer Res Treat; 2019 Oct; 177(3):569-579. PubMed ID: 31292800
[TBL] [Abstract][Full Text] [Related]
11. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
[TBL] [Abstract][Full Text] [Related]
12. Association of myosteatosis with treatment response and survival in patients with hepatocellular carcinoma undergoing chemoembolization: a retrospective cohort study.
Bannangkoon K; Hongsakul K; Tubtawee T; Ina N; Chichareon P
Sci Rep; 2023 Mar; 13(1):3978. PubMed ID: 36894658
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
[TBL] [Abstract][Full Text] [Related]
14. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
15. Association of pre-diagnostic physical exercise and peri-diagnostic body composition with mortality in non-metastatic colorectal cancer.
Renman D; van Guelpen B; Anderson F; Axelsson J; Riklund K; Strigård K; Palmqvist R; Gunnarsson U; Gylling B
Int J Colorectal Dis; 2023 Sep; 38(1):239. PubMed ID: 37755537
[TBL] [Abstract][Full Text] [Related]
16. Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment.
Ahern E; Brown TE; Campbell L; Hughes BGM; Banks M; Lin CY; Kenny LM; Bauer J
Br J Nutr; 2023 Feb; 129(3):406-415. PubMed ID: 35152926
[TBL] [Abstract][Full Text] [Related]
17. The use of computed tomography images as a prognostic marker in critically ill cancer patients.
Toledo DO; Carvalho AM; Oliveira AMRR; Toloi JM; Silva AC; Francisco de Mattos Farah J; Prado CM; Silva JM
Clin Nutr ESPEN; 2018 Jun; 25():114-120. PubMed ID: 29779805
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer: results from the ABLE feasibility trial.
Delrieu L; Martin A; Touillaud M; Pérol O; Morelle M; Febvey-Combes O; Freyssenet D; Friedenreich C; Dufresne A; Bachelot T; Heudel PE; Trédan O; Crochet H; Bouhamama A; Pilleul F; Pialoux V; Fervers B
Breast Cancer Res Treat; 2021 Aug; 188(3):601-613. PubMed ID: 34013451
[TBL] [Abstract][Full Text] [Related]
19. Effect of muscle depletion on survival in peripheral arterial occlusive disease: Quality over quantity.
Vedder IR; Levolger S; Dierckx RAJO; Zeebregts CJ; de Vries JPM; Viddeleer AR; Bokkers RPH
J Vasc Surg; 2020 Dec; 72(6):2006-2016.e1. PubMed ID: 32330596
[TBL] [Abstract][Full Text] [Related]
20. Myosteatosis, the More Significant Predictor of Outcome: An Analysis of the Impact of Myosteatosis, Sarcopenia, and Sarcopenic Obesity on Liver Transplant Outcomes in Johannesburg, South Africa.
Irwin NEA; Fabian J; Hari KR; Lorentz L; Mahomed A; Botha JF
Exp Clin Transplant; 2021 Sep; 19(9):948-955. PubMed ID: 34387151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
